CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
people who have a kidney disease called autosomal dominant polycystic kidney disease (ADPKD)....
Phase 1
Madrid, Spain and 17 other locations
Roxadustat is a licensed medicine to treat anemia in adults with chronic kidney disease (CKD). Anemia is a low level of red blood c...
Phase 3
Madrid, Spain and 37 other locations
The main purpose of this study is to investigate the efficacy and safety of Volenrelaxin in adults with Chronic Kidney Disease. The...
Phase 2
Majadahonda, Madrid, Comunidad De, Spain and 18 other locations
and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...
Phase 3
Majadahonda, Spain and 319 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
Madrid, Spain and 295 other locations
The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney...
Phase 2
Madrid, Spain and 100 other locations
Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial ...
Phase 3
Madrid, Spain and 338 other locations
Researchers are looking for a better way to treat people who have chronic kidney disease (CKD), CKD is a condition in which the kidneys...
Phase 2
Madrid, Spain and 167 other locations
Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys...
Phase 3
Madrid, Spain and 84 other locations
This study will look if CagriSema can lower kidney damage in people with chronic kidney disease (CKD), type 2 diabetes (T2...
Phase 2
Madrid, Spain and 119 other locations
Clinical trials
Research sites
Resources
Legal